Genomic variants associated with primary biliary cirrhosis

Genome Medicine

Volumn 2, Issue 1, 2010, Pages

  Selmi, Carlo ^a,b   Torok, Natalie J ^c   Affronti, Andrea ^b   Gershwin, M Eric ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P35; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; MITOCHONDRION ANTIBODY; STAT4 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; URSODEOXYCHOLIC ACID;

EPIGENETICS; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOMICS; HUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

EID: 78751688616     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm126     Document Type: Review

References (102)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273. 10.1056/NEJMra043898, 16177252.
2. Selmi C, Zuin M, Bowlus CL, Gershwin ME. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis 2008, 12:173-185. ix, 10.1016/j.cld.2007.11.008, 18242503.
3. Kikuchi K, Lian ZX, Yang GX, Ansari AA, Ikehara S, Kaplan M, Miyakawa H, Coppel RL, Gershwin ME. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005, 128:304-312. 10.1053/j.gastro.2004.11.005, 15685542.
4. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 2005, 25:298-310. 10.1055/s-2005-916321, 16143945.
5. Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, Worman HJ, Gershwin ME, Podda M, Invernizzi P. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006, 43:1135-1144. 10.1002/hep.21172, 16628641.
6. Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 2005, 42:386-392. 10.1016/j.jhep.2004.11.016, 15710222.
7. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7:626-630. 10.1016/j.autrev.2008.06.009, 18603021.
8. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999, 30:402-407. 10.1016/S0168-8278(99)80097-X, 10190721.
9. Invernizzi P, Gershwin ME. The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology 2008, 135:1044-1047. 10.1053/j.gastro.2008.08.020, 2629658, 18773895.
10. Lazaridis KN, Talwalkar JA. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. J Clin Gastroenterol 2007, 41:494-500. 10.1097/01.mcg.0000225653.07932.8f, 17450033.
11. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009, 33:197-207. 10.1016/j.jaut.2009.09.008, 2783422, 19819109.
12. Selmi C, Invernizzi P, Zuin M, Podda M, Gershwin ME. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis 2005, 25:265-280. 10.1055/s-2005-916319, 16143943.
13. Invernizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, Zuin M, Podda M. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 1997, 25:1090-1095. 10.1002/hep.510250507, 9141422.
14. Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y, Tsuneyama K, Nakamura M, Komori A, Migita K, Nakanuma Y, Ishibashi H, Selmi C, Gershwin ME. Biliary epithelial cells and primary biliary cirrhosis: The role of liver-infiltrating mononuclear cells. Hepatology 2008, 47:958-965. 10.1002/hep.22102, 18181218.
15. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005, 42:1194-1202. 10.1002/hep.20907, 16250040.
16. Gong Y, Huang ZB, Christensen E, Gluud C. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2008, 3:CD000551.
17. Neuberger J. Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence. J Hepatol 2003, 39:142-148. 10.1016/S0168-8278(03)00283-6, 12873808.
18. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987, 138:3525-3531.
19. Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Water J, Gershwin ME. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879. 10.1002/hep.22736, 2665925, 19185000.
20. Agmon-Levin N, Ram M, Barzilai O, Porat-Katz BS, Parikman R, Selmi C, Gershwin ME, Anaya JM, Youinou P, Bizzaro N, Tincani A, Tzioufas AG, Cervera R, Stojanovich L, Martin J, Gonzalez-Gay MA, Valentini G, Blank M, SanMarco M, Rozman B, Bombardieri S, De Vita S, Shoenfeld Y. Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun 2009, 32:261-266. 10.1016/j.jaut.2009.02.017, 19356903.
21. Selmi C, Invernizzi P, Keefe EB, Coppel RL, Podda M, Rossaro L, Ansari AA, Gershwin ME. Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol 2004, 38:264-271. 10.1097/00004836-200403000-00013, 15128074.
22. Christen U, Hintermann E, Holdener M, von Herrath MG. Viral triggers for autoimmunity: Is the 'glass of molecular mimicry' half full or half empty?. J Autoimmun 2009,
23. Jones DE, Donaldson PT. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 2003, 7:841-864. 10.1016/S1089-3261(03)00095-3, 14594133.
24. Invernizzi P, Selmi C, Mackay IR, Podda M, Gershwin ME. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2005, 3:401-410. 10.1016/S1542-3565(04)00678-0, 15880308.
25. Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, Almasio P, Rosina F, Marzioni M, Fabris L, Muratori L, Qi L, Seldin MF, Gershwin ME, Podda M. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008, 48:1906-1912. 10.1002/hep.22567, 2592501, 19003916.
26. McCluskey J, Peh CA. The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenet 1999, 1:3-20.
27. Ercilla G, Parés A, Arriaga F, Bruguera M, Castillo R, Rodés J, Vives J. Primary biliary cirrhosis associated with DLA-DRw3. Tissue Antigens 1979, 14:449-452. 10.1111/j.1399-0039.1979.tb00874.x, 12731577.
28. Miyamori H, Kato Y, Kobayashi K, Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion 1983, 26:213-217. 10.1159/000198892, 6409699.
29. Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, Saibara T, Yamamoto Y. DNA typing of HLA class II genes; DRB1 0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 1994, 21:1053-1060. 10.1016/S0168-8278(05)80617-8, 7699227.
30. Bassendine MF, Dewar PJ, James OF. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 1985, 26:625-628. 10.1136/gut.26.6.625, 1432751, 3859460.
31. Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 1987, 29:141-145. 10.1111/j.1399-0039.1987.tb01566.x, 3496684.
32. Manns MP, Bremm A, Schneider PM, Notghi A, Gerken G, Prager-Eberle M, Stradmann-Bellinghausen B, Meyer zum Buschenfelde KH, Rittner C. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991, 101:1367-1373.
33. Morling N, Dalhoff K, Fugger L, Georgsen J, Jakobsen B, Ranek L, Odum N, Svejgaard A. DNA polymorphism of HLA class II genes in primary biliary cirrhosis. Immunogenetics 1992, 35:112-116.
34. Invernizzi P, Battezzati PM, Crosignani A, Perego F, Poli F, Morabito A, De Arias AE, Scalamogna M, Zuin M, Podda M. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003, 38:401-406. 10.1016/S0168-8278(02)00440-3, 12663229.
35. Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology 1987, 7:889-892. 10.1002/hep.1840070516, 3498674.
36. Begovich AB, Klitz W, Moonsamy PV, Water J, Peltz G, Gershwin ME. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994, 43:71-77. 10.1111/j.1399-0039.1994.tb02303.x, 8016844.
37. Wassmuth R, Depner F, Danielsson A, Hultcrantz R, Loof L, Olson R, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindgren S. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 2002, 59:381-387. 10.1034/j.1399-0039.2002.590504.x, 12144621.
38. Mullarkey ME, Stevens AM, McDonnell WM, Loubiere LS, Brackensick JA, Pang JM, Porter AJ, Galloway DA, Nelson JL. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 2005, 65:199-205. 10.1111/j.1399-0039.2005.00351.x, 15713222.
39. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001, 48:397-402. 10.1136/gut.48.3.397, 1760119, 11171832.
40. Zhang L, Weetman AP, Bassendine M, Oliveira DB. Major histocompatibility complex class-II alleles in primary biliary cirrhosis. Scand J Immunol 1994, 39:104-106. 10.1111/j.1365-3083.1994.tb03346.x, 7904771.
41. Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2003, 18:1061-1066. 10.1046/j.1440-1746.2003.03091.x, 12911663.
42. Mella JG, Roschmann E, Maier KP, Volk BA. Association of primary biliary cirrhosis with the allele HLA-DPB1 0301 in a German population. Hepatology 1995, 21:398-402.
43. Seki T, Kiyosawa K, Ota M, Furuta S, Fukushima H, Tanaka E, Yoshizawa K, Kumagai T, Mizuki N, Ando A, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1 0501 in Japanese patients. Hepatology 1993, 18:73-78. 10.1002/hep.1840180113, 8100798.
44. Donaldson PT. TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J Hepatol 1999, 31:366-368. 10.1016/S0168-8278(99)80238-4, 10453954.
45. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992, 1:353. 10.1093/hmg/1.5.353, 1363876.
46. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199. 10.1073/pnas.94.7.3195, 20345, 9096369.
47. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997, 34:391-399. 10.1016/S0161-5890(97)00052-7, 9293772.
48. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 1997, 17:631-635. 10.1089/jir.1997.17.631, 9355965.
49. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. [see comments]. J Hepatol 1999, 31:242-247. 10.1016/S0168-8278(99)80220-7, 10453936.
50. Tanaka A, Quaranta S, Mattalia A, Coppel R, Rosina F, Manns M, Gershwin ME. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol 1999, 30:826-829. 10.1016/S0168-8278(99)80135-4, 10365808.
51. Jones DE, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, Day CP, James OF, Bassendine MF. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. [see comments]. J Hepatol 1999, 30:232-236. 10.1016/S0168-8278(99)80067-1, 10068101.
52. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989, 10:1-7. 10.1002/hep.1840100102, 2737595.
53. Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 2000, 12:1329-1333. 10.1097/00042737-200012120-00011, 11192323.
54. Fan LY, Zhong RQ, Tu XQ, Thomas P, Ralph F, Zhu Y, Zhou L. [Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population]. Zhonghua Gan Zang Bing Za Zhi 2004, 12:160-162.
55. Jazrawi SF, Zaman A, Muhammad Z, Rabkin JM, Corless CL, Olyaei A, Biggs A, Ham J, Chou S, Rosen HR. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Liver Transpl 2003, 9:377-382. 10.1053/jlts.2003.50064, 12682890.
56. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002, 4:45-61. 10.1097/00125817-200203000-00002, 11882781.
57. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000, 32:538-541. 10.1016/S0168-8278(00)80213-5, 10782900.
58. Fan LY, Tu XQ, Cheng QB, Zhu Y, Feltens R, Pfeiffer T, Zhong RQ. Cytotoxic Tlymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol 2004, 10:3056-3059.
59. Kershenobich D, Rojkind M, Quiroga A, Alcocer-Varela J. Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology 1990, 11:205-209. 10.1002/hep.1840110208, 2137807.
60. Lakatos LP, Bajnok E, Hegedus D, Toth T, Lakatos P, Szalay F. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2002, 14:733-740. 10.1097/00042737-200207000-00004, 12169981.
61. Fan LY, Zhu Y, Zhong RQ, Tu XQ, Ye WM, Chen QB, Zeng WJ, Kong XT. [Genetic association between interleukins gene polymorphisms with primary biliary cirrhosis in Chinese population]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004, 26:505-509.
62. Fan LY, Tu XQ, Zhu Y, Pfeiffer T, Feltens R, Stoecker W, Zhong RQ. Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. World J Gastroenterol 2005, 11:2768-2772.
63. Matsushita M, Tanaka A, Kikuchi K, Kitazawa E, Kawaguchi N, Kawashima Y, Kato T, Fujikawa H, Quaranta S, Rosina F, Gershwind ME, Miyakawa H. Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients. Autoimmunity 2002, 35:531-536. 10.1080/0891693021000056703, 12765479.
64. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002, 35:126-131. 10.1053/jhep.2002.30084, 11786968.
65. Halmos B, Szalay F, Cserniczky T, Nemesanszky E, Lakatos P, Barlage S, Schmitz G, Romics L, Csaszar A. Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population. Dig Dis Sci 2000, 45:1091-1095. 10.1023/A:1005581414918, 10877221.
66. Fan LY, Zhong RQ, Tu XQ, Zhu Y, Gong CL, Zhou L, Zhao ZX, Feltens R, Pfeiffer T. [Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune liver diseases on Chinese]. Zhonghua Yi Xue Za Zhi 2003, 83:1852-1855.
67. Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000, 118:145-151. 10.1016/S0016-5085(00)70423-9, 10611163.
68. Pares A, Guanabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, Caballeria L, Monegal A, Salvador G, Jo J, Peris P, Rivera F, Ballesta AM, Rodes J. Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 2001, 33:554-560. 10.1053/jhep.2001.22758, 11230734.
69. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004, 39:476-483. 10.1002/hep.20049, 14768001.
70. Pauli-Magnus C, Kerb R, Fattinger K, Lang T, Anwald B, Kullak-Ublick GA, Beuers U, Meier PJ. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 2004, 39:779-791. 10.1002/hep.20159, 14999697.
71. Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, Zimmermann R, Kenngott S, Beuers U, Reichel C, Kerb R, Penger A, Meier PJ, Kullak-Ublick GA. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004, 14:91-102. 10.1097/00008571-200402000-00003, 15077010.
72. Juran BD, Atkinson EJ, Larson JJ, Schlicht EM, Lazaridis KN. Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis. Am J Gastroenterol 2009, 104:1406-1411. 10.1038/ajg.2009.103, 2853916, 19491853.
73. Kimura Y, Selmi C, Leung PS, Mao TK, Schauer J, Watnik M, Kuriyama S, Nishioka M, Ansari AA, Coppel RL, Invernizzi P, Podda M, Gershwin ME. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology 2005, 41:55-63. 10.1002/hep.20516, 15690482.
74. Xu L, Guo L, Shen Z, Loss G, Gish R, Wasilenko S, Mason AL. Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis. Liver Int 2009, 29:375-383. 10.1111/j.1478-3231.2008.01888.x, 19018986.
75. Zhong B, Strnad P, Selmi C, Invernizzi P, Tao GZ, Caleffi A, Chen M, Bianchi I, Podda M, Pietrangelo A, Gershwin ME, Omary MB. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology 2009, 50:546-554. 10.1002/hep.23041, 2756069, 19585610.
76. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Gu X, Walker EJ, Jing K, Juran BD, Mason AL, Myers RP, Peltekian KM, Ghent CN, Coltescu C, Atkinson EJ, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555. 10.1056/NEJMoa0810440, 2857316, 19458352.
77. Yoshida K, Yang GX, Zhang W, Tsuda M, Tsuneyama K, Moritoki Y, Ansari AA, Okazaki K, Lian ZX, Coppel RL, Mackay IR, Gershwin ME. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 2009, 50:1494-1500. 10.1002/hep.23132, 2783300, 19676134.
78. Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers?. Autoimmun Rev 2003, 2:133-139. 10.1016/S1568-9972(02)00149-0, 12848954.
79. Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev 2004, 3:454-463. 10.1016/j.autrev.2004.06.004, 15351311.
80. Fanning PA, Jonsson JR, Clouston AD, Edwards-Smith C, Balderson GA, Macdonald GA, Crawford DH, Kerlin P, Powell LW, Powell EE. Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol 2000, 33:690-695. 10.1016/S0168-8278(00)80297-4, 11097474.
81. Tanaka A, Lindor K, Gish R, Batts K, Shiratori Y, Omata M, Nelson JL, Ansari A, Coppel R, Newsome M, Gershwin ME. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 1999, 30:833-838. 10.1002/hep.510300410, 10498630.
82. Invernizzi P, De Andreis C, Sirchia SM, Battezzati PM, Zuin M, Rossella F, Perego F, Bignotto M, Simoni G, Podda M. Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 2000, 122:418-422. 10.1046/j.1365-2249.2000.01381.x, 1905811, 11122249.
83. Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16. 10.1016/j.jaut.2009.03.005, 19356902.
84. Invernizzi P, Miozzo M, Battezzati PM, Bianchi I, Grati FR, Simoni G, Selmi C, Watnik M, Gershwin ME, Podda M. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004, 363:533-535. 10.1016/S0140-6736(04)15541-4, 14975617.
85. Miozzo M, Selmi C, Gentilin B, Grati FR, Sirchia S, Oertelt S, Zuin M, Gershwin ME, Podda M, Invernizzi P. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007, 46:456-462. 10.1002/hep.21696, 17659578.
86. Lleo A, Selmi C, Invernizzi P, Podda M, Gershwin ME. The consequences of apoptosis in autoimmunity. J Autoimmun 2008, 31:257-262. 10.1016/j.jaut.2008.04.009, 2637382, 18513925.
87. Larizza D, Calcaterra V, Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 2009, 33:25-30. 10.1016/j.jaut.2009.03.002, 19349146.
88. Persani L, Rossetti R, Cacciatore C, Bonomi M. Primary ovarian insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009, 33:35-41. 10.1016/j.jaut.2009.03.004, 19346101.
89. Pessach IM, Notarangelo LD. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun 2009, 33:17-24. 10.1016/j.jaut.2009.03.003, 19361956.
90. Sawalha AH, Harley JB, Scofield RH. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 2009, 33:31-34. 10.1016/j.jaut.2009.03.006, 2885450, 19464849.
91. Sanchez-Pernaute O, Ospelt C, Neidhart M, Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 2008, 30:12-20. 10.1016/j.jaut.2007.11.006, 18155418.
92. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429:457-463. 10.1038/nature02625, 15164071.
93. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009, 33:3-11. 10.1016/j.jaut.2009.03.007, 2819418, 19349147.
94. Huang Q, Parfitt A, Grennan DM, Manolios N. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity 1997, 26:85-93. 10.3109/08916939709003851, 9546817.
95. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990, 33:1665-1673. 10.1002/art.1780331109, 2242063.
96. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, Chieco-Bianchi L. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995, 1:1279-1283. 10.1038/nm1295-1279, 7489409.
97. Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL, Richardson BC. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993, 92:38-53. 10.1172/JCI116576, 293525, 7686923.
98. Oelke K, Lu Q, Richardson D, Wu A, Deng C, Hanash S, Richardson B. Overexpression of CD70 and overstimulation of IgG synthesis by lupus Tcells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004, 50:1850-1860. 10.1002/art.20255, 15188362.
99. Padgett KA, Lan RY, Leung PC, Lleo A, Dawson K, Pfeiff J, Mao TK, Coppel RL, Ansari AA, Gershwin ME. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 2009, 32:246-253. 10.1016/j.jaut.2009.02.022, 2698796, 19345069.
100. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, de Bakker PI, Le JM, Lee HS, Batliwalla F, Li W, Masters SL, Booty MG, Carulli JP, Padyukov L, Alfredsson L, Klareskog L, Chen WV, Amos CI, Criswell LA, Seldin MF, Kastner DL, Gregersen PK. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986. 10.1056/NEJMoa073003, 2630215, 17804842.
101. Invernizzi P, Gershwin ME. The genetics of human autoimmune disease. J Autoimmun 2009, 33:290-299. 10.1016/j.jaut.2009.07.008, 19682858.
102. Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009, 32:189-194. 10.1016/j.jaut.2009.02.012, 2717629, 19303254.